(Q40374501)

19 September 2017

1 reference

title

Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride (English)

1 reference

19 September 2017

Palmer GC

1

1 reference

19 September 2017

Cregan EF

series ordinal

2

1 reference

19 September 2017

Borrelli AR

series ordinal

3

1 reference

19 September 2017

Willett F

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

Annals of the New York Academy of Sciences

19 September 2017

published in

1 reference

19 September 2017

volume

765

1 reference

19 September 2017

page(s)

236-47; discussion 248

1 reference

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

MK-801 reduced cerebral ischemic injury by inducing hypothermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Protection by NMDA antagonists against selective cell loss following transient ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Dementia with bilateral medial temporal lobe ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

A new model of temporary focal neocortical ischemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Partition of the human cerebellum in sensory-motor activities, learning and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Capillary NMDA receptors regulate blood-brain barrier function and breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

Cerebrovascular disease and functional outcome after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB16580.X

10.1111/J.1749-6632.1995.TB16580.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference